Subarachnoid Hemorrhage
Subarachnoid hemorrhage (SAH) is a medical emergency characterized by bleeding in the space between the brain and the tissues covering it, often leading to severe headaches and other neurological symptoms.
Subarachnoid Hemorrhage: EDV2209 Medication Study
We are investigating the safety and tolerability of a new medication, EDV2209, for patients with bleeding in the brain. This study compares the effects of EDV2209 to a placebo to see how it may help in recovery.
>2 yearsSafety phase (I)Efficacy phase (II)Investigational MedicinesInjectionInternal MedicineNeurology
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 80 years old?
- Do you have moderate or severe subarachnoid hemorrhage (SAH) caused by a ruptured aneurysm with symptoms starting less than 8 hours ago?
- Do you have any severe or unstable health conditions that could affect your safety in the trial?
- Are you pregnant or breastfeeding?
- Have you participated in any other clinical trial with an experimental drug in the last 12 weeks?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
4-bis(o-aminophenylmercapto)butadiene hemiethanolate
3-dicyano-1
4-diamino-2
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Rigshospitalet
Department Of Neurology
Copenhagen, Denmark
Odense University Hospital
Department of Neurosurgery
Odense, Denmark
Sponsor: Edvince AB
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.